year
thought
malign
spirit
caus
diseas
end
nineteenth
centuri
belief
displac
modern
concept
diseas
name
formul
germ
theori
assert
bacteria
microorgan
caus
diseas
emerg
chronic
degen
autoimmun
diseas
last
centuri
caus
role
microorgan
intens
debat
howev
clear
explanatori
model
achiev
review
examin
current
avail
literatur
regard
relationship
infect
autoimmun
diseas
critic
analyz
clinic
serolog
molecular
associ
review
experiment
model
induct
altern
protect
autoimmun
diseas
infect
review
sever
studi
report
clinic
experiment
pattern
emerg
chronic
multipl
infect
virus
epsteinbarr
viru
cytomegaloviru
bacteria
h
pylori
may
suscept
individu
play
role
evolv
autoimmun
diseas
vast
major
infect
pertain
resid
microbiota
endogen
retrovirus
healthi
carriag
infect
rule
propos
focu
understand
mechan
healthi
carrier
state
chang
configur
infecti
syndrom
restor
health
sustain
ill
chronic
state
andor
autoimmun
diseas
seem
develop
healthi
carriag
state
infect
colon
earli
stage
ontogenesi
key
microorgan
also
call
old
friend
lactobacilli
bifidobacteria
among
other
import
healthi
live
protect
infecti
autoimmun
syndrom
year
physician
believ
diseas
caus
dyscrasia
ie
imbal
bodi
humor
blood
phlegm
black
yellow
bile
medic
belief
domin
medic
think
nineteenth
centuri
challeng
rudolf
virchow
cellular
patholog
state
diseas
deriv
perturb
cellular
behavior
later
loui
pasteur
propos
germ
theori
robert
koch
postul
lead
medic
scientif
commun
accept
infecti
origin
diseas
herald
new
period
medicin
biolog
hundr
new
diseas
describ
new
techniqu
diagnosi
treatment
develop
parallel
phenomena
immun
capac
resist
infect
start
systemat
studi
henc
give
birth
immunolog
introduct
basic
sanitari
system
antibiot
infect
mortal
decreas
chronic
degen
diseas
name
atherosclerosi
cancer
autoimmun
diseas
emerg
lead
caus
morbid
mortal
least
western
world
diseas
inflammatoryimmun
basi
distinct
infecti
diseas
inflammatori
autoimmun
diseas
clearcut
well
recogn
viral
bacteri
parasit
infect
may
involv
arous
flare
hand
prevent
autoimmun
diseas
purpos
review
examin
stateoftheart
research
relationship
infect
autoimmun
diseas
herein
examin
clinic
serolog
molecular
associ
infect
autoimmun
diseas
addit
review
experiment
model
develop
induct
protect
autoimmun
infect
occurr
rheumatoid
arthriti
ra
associ
sever
infect
among
epsteinbarr
viru
ebv
parvo
chronic
hepat
c
earlier
studi
patient
ra
exhibit
increas
titer
antiebv
nuclear
antigen
antibodi
increas
frequenc
circul
ebvinfect
b
cell
compar
healthi
control
recent
also
shown
tenfold
increas
ebv
dna
load
sever
similar
exist
ra
parvo
infect
state
character
chronic
cours
morn
stiff
joint
deform
destruct
rheumatoid
nodul
well
induct
rheumatoid
factor
rf
cytokin
transform
growth
case
report
ra
develop
acut
parvo
infect
persist
rna
antigen
synovi
tissu
ra
patient
studi
bone
marrow
sampl
ra
patient
posit
parvoviru
compar
histor
control
group
bone
marrow
regard
bacteri
infect
ra
consist
associ
high
titer
antibodi
proteu
mirabili
prospect
studi
patient
recent
diagnos
inflammatori
arthriti
follow
year
patient
sera
test
panel
microorgan
proteu
mirabili
escherichia
coli
chlamydia
trachomati
salmonella
typhi
shigella
fexneri
campylobac
jejun
yersinia
enterocolitica
parvoviru
almost
half
patient
fulfil
american
colleg
rheumatolog
criteria
ra
fulfil
european
spondyloarthropathi
studi
group
essg
criteria
spondyloarthropathi
undifferenti
arthriti
igm
iga
antiproteu
mirabili
antibodi
significantli
higher
patient
posit
rf
compar
patient
group
p
addit
anti
coli
igm
antibodi
also
elev
rfposit
ra
patient
suggest
role
p
mirabili
e
coli
infect
earli
seroposit
ra
experiment
model
induct
infect
skg
mice
spontan
develop
cellmedi
chronic
autoimmun
arthriti
togeth
product
sever
autoantibodi
includ
rf
extraarticular
lesion
mice
fail
develop
arthriti
microbi
clean
environ
howev
singl
intraperiton
inject
zymosan
crude
yeast
cell
wall
extract
provok
sever
arthriti
main
constitu
zymosan
respons
arthritogen
effect
blockad
major
receptor
abl
prevent
skg
arthriti
trigger
antibiot
treatment
fungi
prevent
skg
arthriti
arthritispron
microbi
environ
effect
microbi
dose
collageninduc
arthriti
cia
demonstr
regard
mycobacterium
tuberculosi
cia
induc
even
ciaresist
b
background
mice
mice
immun
cii
emulsifi
cfa
contain
high
low
dose
tuberculosi
high
dose
tuberculosi
seem
requir
matur
dendrit
cell
enough
prime
helper
cell
specif
cii
antigen
drain
lymph
node
background
mice
use
mycobacterium
avium
intraderm
inject
induc
arthriti
research
character
import
chemokin
receptor
arthritispron
mous
strain
increas
suscept
autoimmun
arthriti
induc
immun
collagen
type
ii
cii
complet
freund
adjuv
cfa
intraderm
infect
avium
similar
arthriti
phenotyp
detect
mice
balbc
background
find
demonstr
state
arthriticpron
genet
background
lead
increas
arthriti
suscept
infecti
avium
noninfecti
ciicfa
challeng
vitro
studi
effect
helicobact
pylori
antigen
b
lymphocyt
cultur
autoantibodi
igm
rf
antisinglestrand
dna
antiphosphatidylcholin
antibodi
detect
cultur
supernat
stimul
h
pylori
ureas
thu
seem
certain
bacteria
fungi
activ
arthritogen
cell
evok
autoimmun
arthriti
individu
genet
prone
produc
arthritogen
autoimmun
cell
recent
studi
experiment
arthriti
administr
helminth
extract
prevent
develop
inflammatori
cell
infiltr
extract
protect
cartilag
damag
zymosanarthr
model
anoth
studi
oral
administr
viabl
bacterium
lactobacillu
casei
strain
shirota
lc
dba
mice
reduc
incid
develop
ciiinduc
arthriti
reduc
level
specif
antibodi
cii
serum
compar
control
mice
administr
lc
also
inhibit
delayedtyp
hypersensit
respons
cii
mice
immun
cii
cfa
suppress
ciispecif
secret
interferongamma
splenocyt
ex
vivo
result
suggest
oral
administr
lc
abl
modifi
humor
cellular
immun
respons
cii
modif
could
result
reduct
develop
cia
mice
interestingli
tolerogen
epitop
type
ii
collagen
cii
structur
mimick
epitop
within
platelet
aggregationassoci
protein
paap
streptococcu
sangui
feed
sangui
pup
delay
onset
arthriti
reduc
rate
final
sever
percentag
affect
limb
cell
prime
tolerogen
epitop
cii
prolifer
incub
paap
sangui
paap
gordonii
cii
suggest
antigenspecif
transmucos
tolerogen
effect
therefor
neonat
mice
bacteri
surfac
antigen
mimic
self
transmucos
stimul
antigenspecif
inhibitori
cell
adult
mice
immun
cii
antigenspecif
inhibitori
cell
manifest
later
attenu
arthriti
paap
sangui
appear
activ
adult
memori
type
ii
collagenspecif
cell
suggest
system
challeng
commens
selfmimick
microorgan
may
perpetu
exist
autoimmun
inocul
live
attenu
vaccin
associ
reactiv
arthriti
ra
sever
report
systemat
review
new
onset
relaps
ra
reactiv
chronic
arthriti
associ
follow
vaccin
hepat
b
miniatur
mass
radiographi
mmr
predominantli
rubella
vaccin
tetanu
typhoidparathyphoid
influenza
polio
varicella
bacillu
calmetteguerin
bcg
dtp
diphtheria
tetanu
pertussi
anthrax
transient
arthralgia
acut
arthriti
chronic
arthriti
well
recogn
sinc
introduct
rubella
vaccin
late
risk
factor
associ
effect
femal
gender
older
age
possibl
hla
type
howev
recent
studi
fail
demonstr
increas
risk
chronic
arthropathi
rubella
vaccin
multipl
sclerosi
epidemiolog
studi
shown
signific
higher
preval
antiebv
antibodi
vs
higher
titer
antiebv
viral
capsid
antiebv
nuclear
antibodi
among
ms
patient
compar
control
recent
systemat
review
case
control
studi
compar
ebv
seroposit
risk
ms
odd
ratio
found
two
recent
largecohort
retrospect
studi
strongest
predictor
ms
serum
level
igg
antibodi
ebna
complex
among
individu
later
develop
ms
serum
antibodi
titer
ebna
complex
similar
control
age
year
twoto
threefold
higher
age
year
older
risk
ms
increas
accord
antibodi
titer
rel
risk
person
high
ebna
complex
titer
compar
low
titer
longitudin
analys
fourfold
increas
antiebna
complex
titer
followup
associ
threefold
increas
ms
risk
result
suggest
agedepend
relationship
ebv
infect
develop
ms
addit
work
suggest
earlyinlif
infect
ebv
usual
oligo
asymptomat
protect
effect
oppos
laterinlif
infect
associ
increas
risk
develop
ms
earlier
studi
demonstr
ms
patient
defect
tcell
control
ebvinfect
b
cell
recent
studi
show
increas
frequenc
cell
respond
two
immunodomin
ebv
epitop
addit
author
character
cell
cross
reactiv
ebv
antigen
myelin
basic
protein
higher
titer
measl
antibodi
ms
patient
rais
concern
possibl
causal
associ
howev
concern
abat
introduct
measl
vaccin
follow
sharp
drop
incid
measl
accompani
signific
chang
incid
ms
recent
metaanalysi
ms
patient
found
like
exhibit
chlamydophila
pneumomia
cpn
dna
cerebrospin
fluid
csf
howev
serolog
associ
found
sera
csf
antibodi
cpn
provoc
hypothesi
associ
malaria
develop
ms
present
propos
compar
old
map
malaria
later
distribut
ms
usa
europ
support
assumpt
earli
infect
plasmodium
sp
childhood
prevent
later
ms
diseas
wherea
silent
infect
time
adolesc
later
might
respons
develop
ms
classic
model
multipl
sclerosi
induct
theiler
murin
encephalomyel
viru
tmev
infect
recent
relat
upregul
particular
chemokin
infect
use
transgen
tmev
code
haemophilu
influenza
peptid
mimic
myelin
proteolipid
protein
plp
author
show
rapidonset
demyelin
diseas
mice
author
also
show
import
second
signal
virusactiv
molecul
molecular
mimicri
induc
diseas
tmev
infect
context
induc
diseas
plp
administ
cfa
anoth
recent
work
research
shown
prior
wellresolv
infect
lymphocyt
choriomening
viru
lmcv
neonat
period
predispos
adult
mice
sever
encephalomyel
caus
second
infect
viru
mechan
propos
viral
vu
addit
transgen
anim
model
insert
certain
viral
protein
product
also
associ
induct
multipl
sclerosi
examin
mimic
msrelat
encephalitogen
peptid
known
human
bacteri
viral
peptid
homolog
found
sever
organ
predominantli
nonpathogen
gut
bacteria
suggest
microorgan
respons
autoimmun
activ
ms
might
normal
occur
gut
bacterium
compar
two
mous
strain
one
suscept
resist
enceph
induc
infect
tmev
shown
cell
number
reactiv
viru
capsid
peptid
higher
resist
strain
reveal
role
cell
viral
clearanc
protect
demyelin
diseas
viral
infect
prime
cell
specif
central
nervou
system
cn
antigen
either
molecular
mimicri
cn
protein
cytokin
respons
bystand
activ
murin
model
mice
infect
vaccinia
viru
encod
myelin
protein
develop
clinic
diseas
immun
activ
either
unrel
viru
murin
cytomegaloviru
cfa
oppos
challeng
lmcv
suppress
autoimmun
anoth
murin
model
oral
vaccin
diarrhea
bacteria
capabl
protect
mice
establish
experiment
allerg
encephalomyel
eae
immun
plp
peptid
protect
diseas
accompani
increas
lymphocyt
cultur
supernat
wherea
decreas
secret
cell
demonstr
nonvaccin
mice
interestingli
amelior
eae
report
experiment
infect
bovi
strain
bcg
associ
ms
hepat
b
vaccin
first
report
franc
introduct
recombin
vaccin
ms
develop
women
later
found
overrepres
antigen
strong
famili
histori
ms
recent
three
largescal
case
control
studi
evid
hbv
vaccin
develop
ms
found
sever
virus
propos
associ
type
diabet
mellitu
rubella
coxsackieviru
b
cox
b
rota
mump
cytomegaloviru
cmv
patient
congenit
rubella
syndrom
high
incid
exhibit
antiislet
antiinsulin
antibodi
suggest
possibl
role
rubella
viru
crossreact
demonstr
rubella
capsid
protein
extract
human
rat
pancreat
islet
cell
crossreact
epitop
rubella
viral
protein
cell
isoform
gad
regard
role
cox
b
epidemiolog
studi
reveal
conflict
result
frequenc
anticox
b
antibodi
newli
diagnos
children
compar
nondiabet
control
sever
author
isol
cox
cox
virus
pancrea
patient
acut
onset
could
induc
diabet
suscept
mice
provid
direct
evid
involv
cox
b
infect
develop
sequenc
homolog
noncapsid
protein
cox
viru
gad
express
beta
cell
describ
antibodi
react
gad
detect
patient
provid
mechan
cox
involv
induct
despit
aforement
data
studi
report
conflict
result
consensu
yet
achiev
role
infect
interestingli
children
evalu
multipl
infect
histori
morbilli
parot
rubella
pertussi
varicella
exhibit
higher
risk
anim
model
induc
virus
either
directli
select
infect
pancreat
cell
rubella
cox
virus
indirectli
autoimmun
respons
elicit
virus
kilham
rat
viru
last
shown
activ
macrophag
secret
inflammatori
cytokin
upregul
autoreact
cell
type
cell
therebi
favor
autoimmun
transgen
anim
model
insert
certain
viral
protein
product
associ
induct
nod
mice
model
lymphocyt
prolifer
lymphocyt
loss
known
homeostat
prolifer
occur
oligoclon
expans
highli
associ
diseas
wellknown
associ
lymphopenia
autoimmun
diseas
also
viral
infect
use
transgen
mous
model
diabet
express
lymphocyt
choriomening
viru
glycoprotein
lmcvgp
pancreat
beta
cell
anim
develop
diabet
upon
infect
lmcv
gp
immun
author
character
import
affin
tcr
ligand
well
key
role
regulatori
molecul
cblb
induct
provid
interest
model
show
multifactor
involv
overt
experiment
diseas
sever
virus
among
lcmv
mous
hepat
viru
shown
protect
develop
suscept
rat
bb
nod
mice
complex
relationship
exist
coxsacki
cox
b
infect
one
hand
cox
b
induc
diseas
prior
level
insul
hand
absenc
minimum
threshold
protect
diabet
similarli
encephalomyocard
viru
diabetogen
mice
strain
prevent
nod
mice
prevent
postul
involv
induct
thelper
immun
respons
delet
effector
cell
anoth
exampl
protect
infect
come
studi
show
activ
tolllik
receptor
microbi
element
protect
nod
mice
diabet
corrobor
hygien
hypothesi
suggest
protect
role
infect
autoimmun
diseas
recent
shown
experiment
infect
salmonella
typhimurium
abl
prevent
nod
mice
develop
diabet
even
induct
diseas
cyclophosphamid
similar
inhibitori
effect
also
demonstr
helminth
infect
increas
incid
around
world
rais
concern
potenti
role
vaccin
incit
event
although
one
casecontrol
studi
suggest
earli
vaccin
hemophylu
influenza
b
could
associ
increas
incid
largescal
cohort
studi
follow
finnish
children
period
found
increas
incid
vaccinationag
associ
studi
suggest
system
lupu
erythematosu
sle
patient
unusu
immun
respons
ebv
analys
larg
cohort
appar
healthi
individu
reveal
develop
sle
preced
abnorm
antibodi
respons
appear
antism
kd
ro
autoantibodi
year
clinic
diseas
first
lupusspecif
autoantibodi
aris
particular
antibodi
direct
addit
sever
recent
paper
demonstr
increas
viral
load
increas
number
latent
infect
peripher
b
cell
impair
function
cell
respons
associ
presenc
ebv
dna
sle
patient
compar
control
author
reproduc
similar
find
propos
associ
relat
age
gender
antiebv
immunoglobulin
isotyp
allel
variat
furthermor
posit
associ
demonstr
level
iga
antiebv
antibodi
diseas
activ
sle
infecti
mononucleosi
patient
exhibit
pattern
immunoglobulin
gene
usag
common
oligoclon
b
cell
respons
ebv
infect
express
b
cell
receptor
specif
censor
restor
equilibrium
continu
high
level
sle
might
aris
disord
regul
chronic
reactiv
ebv
anoth
current
view
normal
immun
perturb
ebv
infect
gener
antibodi
particular
antibodi
also
bind
lupusspecif
autoantigen
sm
ro
follow
develop
complex
autoimmun
respons
culmin
clinic
diseas
anoth
notabl
associ
develop
sle
patient
hcv
parvo
infect
attempt
associ
parvoviru
sle
frustrat
howev
acut
infect
parvoviru
associ
diseas
flareup
sever
similar
found
featur
sle
acut
parvo
infect
includ
malar
rash
arthralgia
arthriti
fever
fatigu
lymphadenopathi
well
serolog
marker
chronic
cours
sle
oppos
selflimit
present
parvo
infect
distinguish
two
diseas
regard
cmv
studi
femal
patient
sle
evalu
presenc
quantiti
human
cmv
genom
author
found
viru
genom
patient
wherea
present
healthi
femal
control
p
cumul
evid
causal
effect
infect
sle
remain
prove
except
aforement
extens
data
regard
ebv
recent
shown
ebv
latent
membran
protein
effect
develop
activ
b
cell
induc
hypersensit
tolllik
receptor
tlr
stimul
b
cell
b
cell
known
bearer
tlr
might
suggest
mechanist
link
ebv
infect
sle
studi
show
immun
structur
cmv
antigen
induc
lupusassoci
autoantibodi
sever
glomerulonephr
one
studi
report
idiotypicinduc
experiment
lupu
amelior
diseas
sever
infect
murin
leukemia
viru
mulv
model
explor
possibl
interact
sle
retrovir
infect
hiv
infect
cogit
benefici
immunolog
impact
diseas
activ
sle
although
induct
experiment
sle
report
mice
treat
pristan
hydrocarbon
oil
adjuv
use
vaccin
recent
case
control
studi
sle
patient
fail
demonstr
role
hbv
vaccin
diseas
develop
influenza
vaccin
diseas
activ
antibodi
product
atherosclerosi
bear
inflammatoryimmun
basi
affect
develop
world
popul
first
infect
associ
atherosclerosi
chlamydophila
pneumonia
formerli
known
chlamydia
pneumonia
retrospect
studi
posit
associ
found
antibodi
pathogen
document
atherosclerosi
recent
metaanalysi
confirm
similar
conflict
result
report
associ
cmv
one
associ
consist
literatur
periodont
import
infecti
compon
certain
periodont
microorgan
campylobact
rectu
peptostreptococcu
micro
associ
higher
degre
carotid
intimamedi
wall
thick
ultrasonograph
measur
atherosclerosi
porphyromona
gengivali
promin
compon
oral
flora
also
implic
atherosclerosi
see
microorgan
h
pylori
herp
simplex
viru
hepat
mycoplasma
influenza
viru
member
herp
famili
associ
atherosclerosi
weaker
associ
molecular
mimicri
found
cmv
protein
heat
shock
protein
import
antigen
atherosclerot
process
accordingli
experiment
infect
murin
cytomegaloviru
mcmv
even
inactiv
aggrav
atherosclerosi
mous
model
line
data
link
periodont
atherosclerosi
p
gingivali
infect
shown
acceler
atherosclerosi
apo
e
null
mice
line
recent
epidemiolog
data
experiment
chlamydia
pneumonia
infect
shown
aggrav
atherosclerosi
wildtyp
neither
apo
e
null
mice
similarli
pneumococc
immun
found
decreas
atherosclerosi
mous
model
clinic
associ
infect
antiphospholipid
antibodi
clearli
associ
sever
infect
rang
viral
bacteri
parasit
infect
recent
work
main
infect
agent
associ
antiphospholipid
syndrom
ap
skin
infect
repres
total
hiv
pneumonia
hepat
c
urinari
tract
infect
associ
also
report
ap
chronic
hcv
infect
cmv
ebv
mycoplasma
pulmonari
tuberculosi
malaria
p
carinii
leptospirosi
one
work
show
increas
preval
anticardiolpin
antibodi
iga
isotyp
patient
spastic
paraparesi
ap
group
other
demonstr
homolog
glycoprotein
sever
microbi
protein
identifi
relev
epitop
molecul
group
search
homolog
peptid
sever
microbi
protein
swiss
protein
databas
link
molecular
mimicri
wide
rang
infect
autoimmun
diseas
recent
group
shown
overlap
pattern
antibodi
sera
rheumat
fever
ap
patient
show
titer
function
activ
group
patient
well
antiprotein
titer
ap
patient
provid
datalink
streptococcalinduc
autoimmun
common
ap
rf
like
heart
valv
cn
involv
regard
catastroph
antiphospholipid
syndrom
infect
trigger
factor
identifi
patient
import
caus
death
subset
patient
although
clear
relationship
antiphospholipid
antibodi
infect
exist
particular
microorgan
consist
found
involv
diseas
pathogenesi
immun
mice
bacteri
viral
peptid
share
homolog
domain
rais
titer
anticardiolipin
document
date
studi
publish
demonstr
protect
role
infect
ap
recent
review
pm
consist
associ
parvoviru
hiv
cohort
chronic
hepat
c
patient
occurr
inflammatori
myopahti
individu
serolog
associ
cox
viru
report
pm
dm
patient
rais
concern
agent
group
diseas
recent
cohort
studi
juvenil
dm
signific
serolog
molecular
correl
demonstr
parvoviru
main
experiment
model
pm
chronic
inflammatori
myositi
induc
cox
tucson
viral
epitop
recent
character
mice
experiment
infect
ross
river
viru
also
abl
induc
arthriti
myositi
experiment
infect
trypanosoma
cruzi
induc
myocard
myositi
multipl
infect
differ
strain
protozoan
abl
exacerb
inflammatori
muscular
diseas
best
knowledg
experiment
model
regard
protect
pmdm
infect
publish
vaccin
bcg
vaccin
associ
develop
dermatomyos
three
case
report
increas
occurr
parvoviru
dna
skin
biopsi
sampl
system
sclerosi
ssc
patient
recent
report
compar
healthi
control
particularli
gene
compon
found
ssc
patient
regard
ebv
antibodi
signific
differ
found
ssc
patient
healthi
individu
oppos
rais
titer
antibodi
cmv
matrix
protein
h
pylori
found
sera
ssc
patient
compar
control
use
librari
random
peptid
pool
igg
patient
diffus
limit
ssc
peptid
identifi
react
igg
sera
use
databas
protein
sequenc
author
observ
high
homolog
peptid
autoantigen
ribonucleoprotein
rnp
filarin
cytocrom
c
protein
cmv
furthermor
react
antibodi
induc
apoptosi
human
endotheli
cell
cultur
huvec
thu
possibl
role
cmv
infect
propos
induct
autoantibodi
capabl
induc
apoptosi
endotheli
cell
least
vitro
ssc
mechan
endotheli
cell
damag
regard
ssc
atherosclerosi
recent
review
mice
experiment
mycoplasma
homini
infect
abl
induc
autoantibodi
associ
ssc
experiment
model
publish
primari
vascul
vasculitid
heterogen
group
diseas
character
inflamm
blood
vessel
wall
encompass
sever
disord
accord
size
affect
vessel
takayasu
arter
giant
cell
arter
predominantli
larg
vessel
kawasaki
syndrom
polyarter
nodosa
pan
predomominantli
medium
vessel
wegen
granulomatosi
microscop
polyangi
churgstrauss
syndrom
purpura
essenti
cryoglobulinemia
cutan
leukocytoclast
angiiti
predominantli
small
vessel
secondari
vascul
associ
wide
rang
viral
hepat
c
b
bacteri
staphylococcu
ricketsia
fungal
parasit
infect
group
vascul
unexplain
etiolog
believ
autoimmun
call
primari
relationship
infect
main
interest
excel
review
subject
recent
publish
notabl
associ
infect
hcv
patient
mix
cryoglobulinemia
vasculid
small
seri
vascul
patient
signific
serolog
correl
found
parvoviru
erythroviru
chlamydia
pneumonia
parvoviru
human
herp
viru
suggest
associ
giant
cell
arter
howev
reproduc
date
specif
pathogen
propos
explain
takayasu
arter
pathophysiolog
first
pathogen
associ
pan
hepat
b
viru
widespread
avail
hbv
vaccin
associ
substanti
decreas
besid
hbv
hcv
hiv
also
found
patient
pan
sever
report
suggest
certain
bacteri
infect
streptococcu
sp
klebsiella
sp
pseudomona
sp
yersinia
sp
may
also
associ
regard
wegen
granulomatosi
inconsist
associ
parvoviru
cmv
particular
aureu
report
kawasaki
diseas
consist
associ
particular
infecti
agent
although
associ
report
coxiella
burnetti
ebv
hiv
varicella
zoster
viru
vzv
dengu
viru
pneumonia
recent
controversi
regard
novel
human
corona
viru
hncov
kawasaki
diseas
take
place
literatur
diseas
exhibit
scientif
statu
primari
vascul
consist
associ
although
report
one
includ
herp
simplex
viru
hsv
hcv
sangui
c
pneumonia
hiv
quit
long
list
microorgan
associ
purpura
compris
streptococcu
sp
pneumonia
yersinia
sp
legionella
h
pylori
hbv
hbv
vzv
adenoviru
cmv
tuberculosi
recentlti
bartonella
hensea
serolog
associ
diseas
without
independ
confirm
yet
transgen
mice
defici
receptor
upon
experiment
infect
murin
gammaherpesviru
latenc
period
develop
largecel
vascul
author
character
import
control
reactiv
mice
anoth
model
intraperiton
inject
candida
albican
water
solubl
fraction
prepar
c
albican
cultur
supernat
abl
induc
coronari
arter
hallmark
kawasaki
diseas
relat
complement
activ
lectin
pathway
model
central
nervou
system
vascul
induc
intrathec
inject
streptococcu
pneumonia
type
isol
patient
meningoenceph
shown
delet
tgf
receptor
ii
polymorphonuclear
favor
bacteri
clearanc
prevent
subsequ
cerebr
vascul
final
lp
recent
shown
aggrav
destruct
inflamm
small
vessel
vascul
glomerulonephr
model
induc
antimyeloperoxidas
antibodi
date
experiment
model
character
protect
role
infect
vascul
report
select
case
vaccin
hbv
mump
measl
influenza
varicella
associ
primari
vascul
syndrom
ssj
occurr
report
chronic
hepat
patient
coxsackieviru
rna
found
salivari
biopsi
patient
ssj
increas
frequenc
compar
healthi
control
howev
find
confirm
author
regard
ebv
ssj
patient
exhibit
significantli
higher
titer
igg
ebna
compar
healthi
control
associ
pulmonari
involv
use
transgen
strain
defici
fa
import
protein
apoptosi
induct
author
shown
infect
murin
cmv
induc
chronic
sialaden
resembl
ssj
similarli
infect
murin
leukemia
viru
induc
murin
sever
immunodefici
term
murin
aid
also
abl
gener
sialaden
resembl
ssj
also
exocrin
pancreat
might
provid
model
evalu
associ
ssj
type
diabet
best
knowledg
experiment
model
report
regard
protect
ssj
infect
infect
yersinia
enterocolitica
hypothes
link
autoimmun
thyroid
diseas
grave
hashimoto
diseas
howev
conflict
data
regard
high
preval
infect
healthi
popul
weaken
hypothesi
effort
associ
grave
hashimoto
thyroid
retrovirus
gener
conflict
data
observ
chronic
hcv
infect
consist
treatment
recent
data
point
promin
role
therapi
induct
thyroid
autoimmun
associ
hcv
infect
also
subclin
hypothyroid
observ
individu
hiv
infect
particularli
highli
activ
retrovir
therapi
thyroid
autoimmun
detect
patient
import
role
cytokin
demonstr
develop
hyperthyroid
infect
transgen
adenoviru
bear
thyroidstimul
hormon
tsh
receptor
review
notion
diseas
might
sole
depend
upon
cytokin
group
recent
shown
import
regulatori
cell
treg
diseas
deplet
treg
caus
enhanc
diseas
sever
shown
hashimoto
thyroid
exhibit
thyrocyt
overexpress
toll
like
receptor
import
receptor
pathogen
associ
molecular
pattern
pamp
dsrna
also
shown
infect
influenza
viru
singl
strand
rna
viru
activ
depend
cascad
murin
thyrocyt
cultur
link
innat
immun
respons
observ
hashimoto
thyroid
infecti
stimuli
like
influenza
viru
schistosoma
mansoni
experiment
infect
protect
mice
experiment
grave
diseas
induc
transgen
adenoviru
bear
th
receptor
one
studi
case
autoimmun
parasit
infect
chaga
diseas
chronic
cardiomyopathi
cmp
infect
cruzi
believ
induc
sever
mechan
inflammatori
autoimmun
respons
damag
heart
process
longterm
lead
infect
patient
syndrom
dilat
cmp
heart
failur
provok
antibodi
cell
direct
toward
heart
protein
shown
share
degre
homolog
cruzi
protein
sever
infecti
agent
serolog
molecularli
associ
myocard
dilat
cmp
high
variabl
result
accord
author
microorgan
report
includ
parvoviru
cox
b
cmv
ebv
adenoviru
influenza
hbv
hcv
polioviru
mump
hiv
respiratori
syncyti
viru
varicella
streptococcu
tuberculosi
staphylococcu
toxoplasma
plasmodium
b
burgdoferi
syphili
leptospirosi
recent
isol
case
patient
myopericard
campylobact
sp
enter
report
sever
mous
model
demonstr
role
cox
myocard
includ
transgen
anim
model
shown
stimul
tolllik
receptor
favor
overtur
myocard
induc
cox
b
model
transgen
express
pancrea
initi
protect
mice
develop
myocard
reinforc
multipl
step
diseas
induct
also
occurr
myocard
experiment
infect
mcmv
encephalomyocard
viru
report
number
studi
show
protect
myocard
induc
infect
experiment
model
dissect
activ
cascad
transgen
mice
howev
date
model
found
regard
amelior
myocard
infect
smallpox
vaccin
myopericarditid
report
incid
case
per
day
vaccin
rate
higher
expect
suggest
causal
relationship
inflammatori
bowel
diseas
ibd
encompass
group
diseas
autoimmun
pathophysiolog
includ
mainli
crohn
diseas
cd
ulcer
coliti
uc
associ
sever
infecti
agent
develop
relat
chang
intestin
resid
microflora
ibd
mark
geograph
variat
increas
rate
highsocioeconomicstatu
individu
exhibit
lowest
enter
infect
rate
associ
highest
rate
multipl
sclerosi
associ
report
h
pylori
particular
form
cd
ulcer
colitislik
form
pcr
method
neg
associ
found
form
cd
interestingli
ibd
patient
found
lower
level
antibodi
h
pylori
comparison
healthi
match
control
establish
cd
uc
year
followup
patient
seroposit
yersinia
enterocolitica
infect
also
infect
mycobacterium
avium
paratuberculosi
map
shown
occur
increas
rate
patient
cd
recent
molecular
mimicri
map
protein
selfpeptid
character
crossreact
map
protein
selfpeptid
gastrointestin
glutathion
peroxidas
report
evalu
patient
propos
novel
autoantigen
diseas
infect
microorgan
clostridium
difficil
cmv
entamoeba
hystolitica
might
also
associ
ibd
interestingli
observ
appendectomi
append
incident
decreas
risk
uc
might
increas
risk
develop
cd
recent
review
manipul
intestin
flora
patient
ibd
administr
probiot
ie
lactobacilli
bifidobacteria
among
other
promis
field
current
clinic
trial
investig
shown
intestin
flora
requir
develop
ibd
defici
mice
germfre
counterpart
mice
resist
diseas
interestingli
monocolon
given
bacteri
speci
also
suffici
overtur
enterocol
infect
schistosoma
mansoni
even
administr
egg
benefici
role
prevent
coliti
provok
direct
intrarect
administr
tridinitrobenzen
sulphon
acid
dnb
benefici
effect
shown
tapeworm
hymenolepi
diminuta
anoth
experiment
model
coliti
induc
dnb
effect
depend
also
oral
administr
trichuri
sui
ova
patient
uc
associ
side
effect
clinic
efficaci
regard
probiot
administr
lactobacillu
bifidobacterium
sp
abl
prevent
develop
spontan
coliti
mice
sever
author
suggest
persist
infect
hiv
hcv
h
pylori
associ
itp
sever
studi
demonstr
improv
platelet
count
suppress
erad
infect
suggest
role
persist
antigen
exposur
pathogenesi
itp
hivinfect
patient
immun
platelet
destruct
shown
associ
presenc
crossreact
antibodi
recogn
conform
structur
platelet
gpiiia
role
h
pylori
infect
develop
persist
itp
erad
platelet
count
emerg
sever
small
studi
prospect
clinic
trial
crossreact
plateletassoci
igg
h
pylori
cag
protein
suggest
molecular
mimicri
may
play
key
role
pathogenesi
subset
itp
patient
experiment
infect
lactat
dehydrogenaseelev
viru
mice
treat
monoclon
autoantibodi
platelet
smaller
dose
induc
diseas
found
trigger
develop
sever
thrombocytopenia
author
character
import
phagocytosi
overtur
diseas
recent
use
phage
display
librari
screen
antibodi
glycoprotein
iiia
autoantigen
platelet
patient
hiv
infect
thrombocytopenia
author
show
part
peptid
rescu
antibodi
phage
display
librari
share
high
homolog
protein
also
shown
inhibit
antiplatelet
antibodi
toxic
effect
platelet
vitro
model
publish
experiment
scenario
vaccin
hbv
mmr
associ
itp
acut
itp
develop
shortli
mmr
vaccin
finnish
children
togeth
multipl
case
report
led
establish
causal
polyradicular
neuropathi
associ
consist
way
campylobact
jejuni
haemophilu
influenza
hiv
cmv
also
report
less
strongli
ebv
pneumonia
although
associ
c
jejuni
syndrom
gb
well
document
latest
estim
incid
gb
patient
c
jejuni
enter
rate
greater
gener
popul
associ
gb
h
pylori
infect
also
report
suscept
mice
immun
brucela
melitensi
induc
antigangliosid
antibodi
along
flaccid
limb
weak
importantli
clinic
serolog
effect
enhanc
compar
mice
immun
c
jejuni
addit
c
jejuni
specif
gene
glycosil
lipooligosacharid
shown
play
import
role
induct
antigangliosid
antibodi
molecular
mimicri
immun
transgen
c
jejuni
defici
gene
gener
smaller
titer
antigangliosid
antibodi
less
weak
mice
character
import
bacteri
structur
induct
pathogen
antibodi
best
knowledg
experiment
model
protect
infect
publish
date
associ
influenza
vaccin
gb
document
mass
inocul
usa
swine
flu
anew
jersey
vaccin
recipi
specif
vaccin
rel
risk
develop
gb
excess
nine
case
per
million
confirm
recent
studi
vaccin
advers
event
report
system
examin
case
gb
year
rel
risk
gb
influenza
vaccin
sever
gb
compar
adult
tetanusdiphteria
vaccin
control
group
suggest
causal
associ
less
strong
case
associ
gb
oral
poliovaccin
nationwid
vaccin
campaign
finland
associ
rise
gb
case
howev
evid
suggest
initi
increas
case
preced
campaign
addit
studi
fail
support
associ
prototyp
autoimmun
diseas
induc
bacteri
infect
rheumat
heart
diseas
rhd
occur
approxim
children
oropharyng
infect
group
streptococci
certain
class
ii
hla
haplotyp
implic
pathogenesi
rhd
shown
involv
humor
cellular
immunolog
compon
molecular
mimicri
propos
respons
pathogenesi
diseas
also
show
degener
pattern
tcr
recognit
cell
clone
infiltr
heart
patient
also
respond
protein
subject
lymphoprolif
test
addit
rhd
induc
immun
protein
group
streptococci
interestingli
abrog
diseas
achiev
intranas
administr
protein
epitop
recent
wide
spectrum
pediatr
autoimmun
neuropsychiatr
disord
panda
describ
associ
streptococc
infect
present
clinic
tourett
syndrom
chorea
panda
relat
least
epidemiolog
group
streptococci
infect
clearanc
serum
igg
plasmapheresi
ivig
reposit
associ
remark
clinic
improv
panda
antibas
ganglia
antibodi
associ
diseas
process
review
literatur
associ
infect
autoimmun
diseas
pattern
clinic
associ
emerg
chronic
viral
infect
ebv
cmv
chronic
bacteri
infect
like
h
pylori
frequent
associ
multipl
autoimmun
diseas
inde
experiment
model
confirm
associ
induct
autoimmun
recent
diseas
overtur
found
reli
multipl
step
induct
viral
persist
chronic
infect
b
cell
viral
deja
vu
sever
mechan
propos
role
infecti
agent
induct
autoimmun
diseas
molecular
mimicri
structur
homolog
infecti
host
compon
underli
pathomechan
rheumat
fever
compon
streptococcu
membran
share
homolog
heart
brain
joint
synovium
peptid
suscept
individu
molecular
mimicri
modifi
lymphocyt
reactiv
progress
chronic
fashion
ultim
lead
autoimmun
diseas
molecular
mimicri
consid
put
mechan
also
gb
ap
ms
epitop
spread
appear
new
antibodi
cell
respons
differ
epitop
anoth
antigen
demonstr
experiment
model
human
diseas
sle
author
demonstr
intermolecular
spread
sm
antigen
rnp
reactiv
preclin
diabet
ra
studi
intraand
intermolecular
spread
observ
context
infect
could
play
import
role
either
releas
sequest
antigen
tissu
damag
upregul
display
cryptic
epitop
inflammatori
condit
bystand
activ
anoth
propos
mechan
immun
milieu
prime
microbi
antigenspecif
cell
take
place
potenti
selfreact
cell
activ
prime
reactiv
cell
may
occur
addit
mechan
infecti
agent
tissu
injuri
may
caus
releas
self
antigen
process
present
antigenpres
cell
lead
prime
selfreact
cell
also
superantigen
cell
activ
viral
bacteri
product
crosslink
cell
receptor
mhc
molecul
independ
specif
antigen
recognit
may
favor
induct
autoimmun
diseas
well
known
viral
infect
commonli
produc
transient
autoimmun
respons
usual
direct
blood
cell
transient
elev
autoantibodi
titer
arthriti
parvo
rubella
vast
major
patient
symptom
antibodi
titer
declin
even
case
role
microorgan
well
defin
like
rheumat
fever
streptococcu
pneumonia
group
infect
children
actual
develop
rheumat
fever
therefor
rather
focus
presenc
absenc
microorgan
context
autoimmun
diseas
complex
immunopatholog
interact
organ
microorgan
import
factor
develop
acut
infect
restor
health
develop
chronic
state
autoimmun
diseas
interact
reli
multitud
factor
includ
genet
epigenet
behavior
symbol
factor
discuss
recent
publish
book
caution
appli
leap
experiment
model
autoimmun
diseas
induc
infect
clinic
diseas
experiment
model
ill
occur
particular
circumst
suscept
strain
particular
environment
condit
usag
adjuv
molecul
furthermor
widespread
genet
manipul
anim
molecul
commonplac
model
help
experiment
model
eventu
genet
determin
pathway
reveal
often
determin
remain
unclear
acknowledg
diabet
nod
mice
occur
femal
maintain
specif
pathogenfre
environ
decreas
less
convent
dirtier
environ
regard
protect
autoimmun
diseas
infect
seem
old
friend
ie
helminth
lactobacilli
bifidobacteria
saprophyt
bacteria
resid
flora
associ
inhibit
autoimmun
diseas
experiment
clinic
set
present
clinic
trial
conduct
microorgan
amount
data
accumul
regard
infect
autoimmun
diseas
vast
expand
mayb
need
clearer
definit
immunolog
physiolog
patholog
deviat
need
new
conceptu
framework
differ
approach
tool
alreadi
seen
mani
area
biolog
collect
name
system
biolog
henc
might
reach
clearer
understand
healthi
organ
patholog
deviat
like
infect
autoimmun
diseas
special
today
concept
superorgan
aris
deeper
layer
biolog
fact
compos
bacteria
retrovirus
evidenc
genom
microbiom
analysi
reveal
host
microorgan
yoke
chimera
sort
